Novartis Aktie
105,56
EUR
+1,16
EUR
+1,11
%
98,40
CHF
+0,40
CHF
+0,41
%
Werbung
Novartis Aktie Analyse
21.03.05 | Novartis Kaufen | Helaba Trust | |
16.03.05 | Novartis Outperform | Goldman Sachs | |
11.03.05 | Novartis Buy | Helvea | |
09.03.05 | Novartis Buy | Merrill Lynch | |
24.02.05 | Novartis Overweight | Lehman Brothers | |
22.02.05 | Novartis Buy | Helvea | |
22.02.05 | Novartis Outperform | Goldman Sachs | |
21.02.05 | Novartis Kaufen | Helaba Trust | |
Werbung
|
|||
21.02.05 | Novartis Akkumulieren | Independent Research | |
21.02.05 | Novartis Buy | Helvea | |
09.02.05 | Novartis Buy | Merrill Lynch | |
02.02.05 | Novartis Übergewichten | Reuschel & Co | |
01.02.05 | Novartis Kaufen | SYZ & CO | |
31.01.05 | Novartis Outperform | Credit Suisse First Boston | |
28.01.05 | Novartis Buy | Helvea | |
27.01.05 | Novartis Outperformer | Sparkasse KölnBonn | |
25.01.05 | Novartis Outperform | Goldman Sachs | |
25.01.05 | Novartis Buy | Helvea | |
24.01.05 | Novartis Overweight | Prudential Securities | |
21.01.05 | Novartis Kaufen | Hamburger Sparkasse | |
21.01.05 | Novartis Kaufen | Helaba Trust | |
20.01.05 | Novartis Akkumulieren | Independent Research | |
20.01.05 | Novartis Buy | Helvea | |
19.01.05 | Novartis Kaufen | Helaba Trust | |
18.01.05 | Novartis Buy | AG Edwards | |
18.01.05 | Novartis Outperform | Bear Stearns | |
18.01.05 | Novartis Buy | Merrill Lynch | |
18.01.05 | Novartis Buy | Merrill Lynch | |
18.01.05 | Novartis Buy | Sarasin Research | |
18.01.05 | Novartis Akkumulieren | Independent Research | |
17.01.05 | Novartis Sector Outperform | Vontobel | |
14.01.05 | Novartis Kaufen | Helaba Trust | |
14.01.05 | Novartis Overweight | Lehman Brothers | |
14.01.05 | Novartis Empfehlungsliste | Erste Bank | |
12.01.05 | Novartis Buy | AG Edwards | |
12.01.05 | Novartis Kaufen | Hamburger Sparkasse | |
07.01.05 | Novartis Empfehlungsliste | Erste Bank | |
04.01.05 | Novartis Buy | Deutsche Securities | |
18.01.04 | Novartis Outperform | Goldman Sachs |
Werbung
Werbung